Medicaid has announced that, effective October 1, pharmacy providers must enroll in electronic funds transfer (EFT) to receive fee-for-service pharmacy payments. After this date, paper checks will no longer be issued for pharmacy payments. This change is intended to address issues such as lost checks, payment delays and mailing time, as well as to modify payment security protocols. Providers that still need to enroll in EFT will need to first register with the Prime User Administration Console (UAC). See the UAC Quick Start Guide for step-by-step instructions on the registration process. Once registered, you will have access to the Provider Job Aid/Prime Therapeutics Financial Portal Guide which will provide step-by-step instructions on completing the EFT enrollment process. After submitting your enrollment request, you will receive a phone call within three business days to verify the information you provided. Please make every effort to complete this verification as soon as possible once contacted to avoid any delays in finalizing your enrollment. Questions should be directed to the Prime Therapeutics Provider Support Line at 1-888-277-5510, OPTION 1.
Also in Michigan, Medicaid announced via email that effective August 1, the following brand products will no longer be preferred and will be replaced by their generic alternatives on the preferred drug list (PDL). An updated Brand over Generic List will be posted soon.
- Pradaxa® (dabigatran etexilate)
- Humalog Mix pen (insulin lispro protamine)
- Novolog cartridge (insulin aspart)
For more information, contact NACDS’ Jill McCormack at 717-592-8977.